This company has shut down. Melax Technologies is no longer operating — its last tracked round was a Grant in 2022.
Explore the Startup GraveyardMelax Technologies specializes in machine learning, software, domain, natural language processing and medical coding services.
Melax Technologies has raised $300K in total funding. The most recent round was Grant. The last funding was announced in August 2022.
Melax Technologies's investors include National Institutes of Health, National Institute of Allergy and Infectious Diseases.
Melax Technologies is headquartered in Houston, United States.
Melax Technologies specializes in machine learning, software, domain, natural language processing and medical coding services.
Melax Technologies is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Melax Technologies — Funding & Investors." VCBacked, August 10, 2022, https://www.vcbacked.co/company/melax-technologies. Accessed July 19, 2026.
VCBacked. (2022). Melax Technologies — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/melax-technologies
{{cite web |title=Melax Technologies — Funding & Investors |url=https://www.vcbacked.co/company/melax-technologies |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated